Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner

News   Mar 28, 2012

 
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
 
 
 

RELATED ARTICLES

Holding Infants – or not – Can Leave Traces on Their Genes

News

Children who have been more distressed as infants and have received less physical contact have a molecular profile that is underdeveloped for their age – pointing to the possibility that they are lagging biologically.

READ MORE

Revealing the Role of the Centromere in Down Syndrome

News

The centromere plays a crucial role in the everyday cell division that keeps us healthy but is also potentially involved in birth defects, cancers and other diseases that arise from cell division problems.

READ MORE

Cambridge Epigenetix Appoints Professor Mark Dawson as Scientific Advisor

News

Cambridge Epigenetix (CEGX), a pioneer in the development and application of epigenetic technologies, announced the appointment of leading epigenetics-based therapeutics specialist, Professor Mark Dawson to its Scientific Advisory Board (SAB).

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE